Document is current
Any future updates will be listed below
-
Authors
Guchelaar, Niels A. D. https://orcid.org/0000-0001-8080-9093
Buck, Stefan A. J.
van Doorn, Leni
Hussaarts, Koen G. A. M.
Sandberg, Yorick
van der Padt-Pruijsten, Annemieke
van Alphen, Robbert J.
Poppe-Manenschijn, Laura
Vleut, Isolde
de Bruijn, Peter
van Leeuwen, Roelof W. F.
Mostert, Bianca
Eskens, Ferry A. L. M.
Oomen-de Hoop, Esther
Koolen, Stijn L. W.
Mathijssen, Ron H. J.
-
Funding
Funding for this research was provided by:
Servier
- License Information
-
More Information
Article History
Accepted: 30 May 2024
First Online: 28 June 2024
Declarations
:
: This study was supported by an unrestricted grant by Servier. Servier did not have any role in designing, performing or analysing this study.
: Bianca Mostert received consulting fees from Lilly, Servier, BMS, AstraZeneca and Amgen, and research funding from Sanofi, Pfizer and BMS. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
: The study protocol was written in conformity with the Declaration of Helsinki and approval of the Medical Ethics Committee of the Erasmus Medical Centre (MEC19-0560) and the competent authorities (NL70704.056.19) was obtained.
: All patients provided written informed consent before enrolment.
: Not applicable.
: The data that support the findings of this study are available from the corresponding author, upon reasonable request.
: Not applicable.
: NADG, SAJB, LvD, KGAMH, YS, AvdP-P, RJvA, LP-M, IV, PdB, RWFvL, BM, FALME, EO-dH, SLWK and RHJM wrote the manuscript; SAJB, KGAMH, RWFvL, EO-dH, SLWK and RHJM designed the research; NADG, SAJB, LvD, KGAMH, YS, AvdP-P, RJvA, LP-M, BM, FALME, SLWK and RHJM performed the research; NADG and EO-dH analysed the data; IV and PdB contributed new reagents/analytical tools. All authors approved the final manuscript.
